Gallotta Steven E. purchased $502 of BCBP

Gallotta Steven E. purchased 55 shares of BCB BANCORP INC (BCBP) at $9.13 on 2026-11-02.

Original reporting
SEC EDGAR · Gallotta Steven E.
Published Nov 5, 2026, 3:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 3:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BCBP
Neutral
high confidence
Mentioned
$BCBP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BCBPNeutralLow
01

Why it matters

The disclosed purchase is modest and unlikely to move the stock price materially.

02

Market read

A small insider buy that provides a fresh data point but offers little trading edge.

03

What to watch

Potential upcoming board decisions or strategic moves not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: today on filing

Background

Form 4 filings disclose insider trades and are required by the SEC for directors and officers.

Company-level read

Ticker impact

$BCBPNeutralHigh confidence
Context

Director Gallotta bought 55 shares for $502, increasing his stake to 1,514 shares.

Expected impact

slight positive pressure as the market views the buy as a modest vote of confidence

Evidence & confidence

The transaction size is small relative to market cap and total float, so any price move will be limited.

Market effects

None; the purchase does not affect the banking sector broadly.

No regional impact; confined to BCBP shareholders.

Minimal; isolated insider transaction.

Counterpoint

The purchase may be routine compensation rather than a signal, so traders should ignore it.

Key entities

  • Gallotta Steven E.

    Director of BCB BANCORP INC who executed the purchase.

  • BCB BANCORP INC

    U.S. bank holding company listed on NYSE under ticker BCBP.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BCBPMed

BCB Bancorp Inc (BCBP) (Q3 2026) Earnings Call Highlights: Classified Loans Slashed 70%

BCB Bancorp (BCBP) reported Q3 2026 earnings, highlighting a 70% reduction in classified loans. CEO Thomas O'Brien discussed recapturing deferred tax assets, expense run rates, and cannabis loan transactions. Criticized loans decreased from $207 million to $153 million. The Business Express loan portfolio showed improved performance. The bank completed a successful capital raise and expects better results in Q4.

$BCBPMed

BCB Bancorp, Inc. Announces Results for the Third Quarter 2026

BCB BANCORP INC (BCBP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 C ONTACT : J AWAD C HAUDHRY , EVP, CFO & T REASURER (201) 823-0700 BCB Bancorp, Inc. Announces Results for the Third Quarter 2026; Achieves Substantial Progress Towards Restructured Balance Sheet. • Successfully completed a $98.0 million equity capital raise through

$BCBPMed

Piper Sandler cuts BCB Bancorp stock price target after dilutive offering

Piper Sandler reduced its price target on BCB Bancorp (BCBP) to $9.50 from $11.00, maintaining a Neutral rating. The bank raised $98 million via a dilutive offering, resulting in 41% ownership dilution. Piper Sandler described the capital raise as aggressive but necessary. BCBP reported a loss of $1.11 per share over the last twelve months but expects profitability this year. The stock traded 13% above the deal price post-announcement.